ClearPoint Neuro (CLPT) Interest Coverage Ratio (2011 - 2026)

ClearPoint Neuro's (CLPT) quarterly Interest Coverage Ratio came in at 6.13 in Q1 2026, up 86.72% quarter-over-quarter from 46.2 in Q2 2022.

ClearPoint Neuro (CLPT) Interest Coverage Ratio (2011 - 2026) Analysis & Trends

ClearPoint Neuro has disclosed Interest Coverage Ratio across 12 years of filings, most recently posting 6.13 for Q1 2026.

Interest Coverage Ratio for Q1 2026 came in at 6.13, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 19.16 (changed N/A YoY), and the FY2025 annual result was 10.12, up 73.44% from the prior year.
Interest Coverage Ratio came in at 6.13 for Q1 2026 at ClearPoint Neuro, up from 46.2 in the prior quarter.
In the past five years, Interest Coverage Ratio ranged from a high of 6.13 in Q1 2026 to a low of 46.2 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	7.73
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	6.32
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	8.09
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	12.23
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-2.90
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	5.36
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	20.98
10	ClearPoint Neuro	524.46 Mn	488.86 Mn	7.76 Mn	-6.13

Download Data